The Effects Potato Protein on Rates of Myofibrillar Muscle Protein Synthesis in Young Women
NCT ID: NCT04302038
Last Updated: 2020-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2018-11-01
2019-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Plant-based Blends on Skeletal Muscle Protein Synthesis Rates in Older Adults
NCT05917223
The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise
NCT05020808
Exogenous Ketosis and Muscle Protein Synthesis During Exercise Recovery
NCT06769100
Supplementation of a Leucine-enriched Protein Blend
NCT03796897
Effects of a Multi-ingredient Supplement Study: a Randomized Controlled Trial in Men and Women
NCT03525197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Twenty-four healthy young women (18-29 yrs) will be recruited to participate in this parallel group, double blind, randomized controlled trial. Participants will be randomized to either supplementary isolated potato protein and unilateral resistance training, or unilateral resistance training alone as placebo (with usual dietary practices, protein clamped at 0.8 g/kg/day). Participants will engage in unilateral resistance training 3 times per wk for 2 wk. To assess the anabolic properties of potato protein, the women in the potato protein group will ingest 25 g of isolated potato protein 2 times a day. On the day of resistance exercise one serving will be provided immediately after the cessation of training. The placebo group will follow the same supplement schedule, but with a placebo. Integrated rates of myofibrillar MPS will be assessed with the precursor-product method using deuterium labeled water (70% D2O).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Potato protein
Participants will be provided with 25 g of potato protein twice per day in addition to a diet set at the recommended daily allowance. Total protein intake for this group will be 1.6 g/kg/day
Protein
Additional daily protein provided by potato protein.
Control group
This group will consume protein from food sources set at 0.8 /kg/day including 2 pudding placebo cups per day.
Placebo control
No additional dietary protein (outside of 0.8 g/kg/day as provided by diet)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protein
Additional daily protein provided by potato protein.
Placebo control
No additional dietary protein (outside of 0.8 g/kg/day as provided by diet)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female sex
Exclusion Criteria
* Regular use of: non-steroidal anti-inflammatory drugs
* History of chronic disease
* Current or recently active or remised cancer
* Infectious disease; and/or gastrointestinal disease
* Consuming a vegetarian or vegan diet = Any condition or injury that would preclude them from participating in resistance exercise
18 Years
29 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stuart Phillips
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ivor Wynne Centre
Hamilton, Ca-on, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HIREB 4969
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.